Von Willebrand Factor and ADAMTS13 in Relation to Major Adverse Limb Events in Peripheral Artery Disease. [PDF]
Agid N +5 more
europepmc +1 more source
Complement activation in thrombotic thrombocytopenic purpura [PDF]
Alvarez-Larran +28 more
core +1 more source
Effectiveness of caplacizumab in the first-line treatment for acquired thrombotic thrombocytopenic purpura: single center experience. [PDF]
Belakova KM +13 more
europepmc +1 more source
Emerging from the shadows of congenital TTP. [PDF]
Scully M, Cox C.
europepmc +1 more source
Late Onset of Congenital TTP: Case Presentation and Review of the Literature. [PDF]
Chatzisfetkos A, Bergmann C, Janssen U.
europepmc +1 more source
Is congenital thrombotic thrombocytopenic purpura a risk factor for ischemic osteonecrosis of the hip joint (Legg-Calvé-Perthes disease)? [PDF]
Laemmle A, Lämmle B.
europepmc +1 more source
Case Series and Literature Narrative Review of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Children. [PDF]
Radu LE +9 more
europepmc +1 more source
Association between neutrophil extracellular traps, the Von Willebrand factor axis, and clinical outcome in stable coronary artery disease. [PDF]
Bratseth V +7 more
europepmc +1 more source

